4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-002770
Options or other derivatives
- Chief Medical Officer acquired 356,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Katz Barrett Chief Medical Officer | 2021-01-18 | Grant or award · Employee Stock Option (right to buy) | +356,000 | 356,000 | D | ||
Loading xslF345X03/doc4.xml…